MYRX Projected Dividend Yield
Myrexis, Inc. ( OTCBB : MYRX )Myrexis Inc. was a biopharmaceutical company that generated a pipeline of differentiated drug candidates in oncology and autoimmune diseases. In Feb. 2012, Co. announced that it had suspended development activity on all of Co.'s preclinical and clinical programs and retained Stifel Nicolaus Weisel, an investment banking firm, to assist in reviewing and evaluating a range of strategic alternatives to enhance shareholder value. Thereafter, in Mar. 2012, Co. initiated an alignment of Co.'s resCo.'sces involving a phased reduction in Co.'s workforce from approx. 59 employees to 1 employee as of June 30, 2013. 21 YEAR PERFORMANCE RESULTS |
MYRX Dividend History Detail MYRX Dividend News MYRX Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |